Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.
about
Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?Novel role of nuclear receptor Rev-erbα in hepatic stellate cell activation: potential therapeutic target for liver injuryCurrent status of novel antifibrotic therapies in patients with chronic liver diseasePathobiology of liver fibrosis: a translational success storyAngiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II.Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.Emerging role of liver X receptors in cardiac pathophysiology and heart failure.Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injuryExposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation.Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression.The interaction between HCV and nuclear receptor-mediated pathwaysVitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes.Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease.Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance.Cyanidin-3-O-β-glucoside combined with its metabolite protocatechuic acid attenuated the activation of mice hepatic stellate cells.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF-κB and the PI3K/Akt Signaling Pathway.Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells.Hepatic stellate cells as key target in liver fibrosis.Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signalingRole of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.Liver fibrogenesis in non-alcoholic steatohepatitis.Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization.Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein.Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss.Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis.Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis.A Leveraged Signal-to-Noise Ratio (LSTNR) Method to Extract Differentially Expressed Genes and Multivariate Patterns of Expression From Noisy and Low-Replication RNAseq Data.Liver X receptors regulate hepatic F4/80 + CD11b+ Kupffer cells/macrophages and innate immune responses in mice.Cholesterol Metabolism Altered and FGF21 Levels High After Pediatric Liver Transplantation Despite Normal Serum Lipids
P2860
Q28066233-0B8EBDC4-17A8-4A48-B044-61034416DB80Q28564897-BF118DDC-71B3-4B82-86B3-21691EBFF82AQ30473375-84B7C78E-63D9-422F-9D1C-60352B801559Q34462733-E3878C35-87A1-4BE7-9003-394616734E61Q35025282-D8045AFF-1336-4174-BC41-E7B5AC4B5E7BQ35106991-78993289-F0E4-42E0-9D65-FC169EB02167Q36322805-75B97CE3-5AA7-4EDF-B0FB-BF8AF0C14920Q36505119-B3FA26FE-76F0-4F0E-B685-C17648738BF4Q36591996-2ABEF159-8F71-4F23-86EF-EF2ABE2DE12EQ36689584-0CFE61A5-C74E-4E46-AA4A-5931ED09B860Q36922214-A86C190C-AEAC-4624-B0D5-29BC70A37360Q37219104-B68629C5-21B3-4A6D-8FAA-C93D82F8C46EQ37881205-1505B7F3-FD1F-4150-81A9-3AD2B41768F1Q37882550-72401F59-05D8-4FD5-B681-46AD83260305Q38133807-668FE7A3-E5C7-4E7C-834F-A0FA90B6093AQ38314419-00A793BF-D58E-49B4-946C-3E7D73D3D9E3Q38660727-D27D69AA-DBBE-420B-B482-E5E3655CE50BQ38752520-63092DF6-BD37-4B29-87A7-CFA0189E1B0DQ38816193-BB0A5D64-C409-4B67-8051-296174CF68A8Q38927251-09FB1380-6F48-480A-A42B-BA6F8675AFE6Q39654148-CE7D7273-A5F4-4D9A-801A-7B6AC8C63662Q40200602-E6DE89FC-B6CF-4D75-ABAD-A531BA478CBBQ41090217-7C368ABD-4B30-4B08-9871-07B8E23D039BQ42282775-69562A50-5DC6-4E32-BC57-B154AD2B46FEQ42321514-2B91D8EE-51A9-4D94-B9B7-802E53D43B11Q42417111-69AC9D8E-BA71-49E5-B81D-CF2F16E4CA9EQ42583421-2644A180-767C-49D4-B7D4-B054B4B733A6Q42644386-E7964F04-A360-46A2-BB9D-4BE33BBD6654Q45207632-959E86AE-02DE-47A7-A866-16326B884F9BQ45399660-D2C49547-4743-48E9-ABA1-C63CE9C02C92Q49379771-552DFCFE-2801-40BA-A9CB-E4759276C631Q52578921-C4138B21-3A4A-41C8-A8D8-5D32010697C5Q55092841-AD2AFBCF-5724-401A-ACFF-96DA4664AEE9Q55401276-1EA30BF4-1938-4E2A-A6AA-C7674B950DDBQ57675055-B2C3ED1C-65FF-4396-84AC-E1114EABCD38
P2860
Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@ast
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@en
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@nl
type
label
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@ast
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@en
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@nl
prefLabel
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@ast
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@en
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@nl
P2093
P2860
P1433
P1476
Liver X receptor signaling is ...... ity to fibrotic liver disease.
@en
P2093
Cynthia Hong
Hide Tsukamoto
Jiaohong Wang
Kevin Wroblewski
Simon W Beaven
Steven Bensinger
P2860
P304
P356
10.1053/J.GASTRO.2010.11.053
P407
P577
2010-12-04T00:00:00Z